Actively Recruiting
Studies of Neuregulin/ERBB Signaling in Human Heart
Led by Douglas B. Sawyer · Updated on 2025-04-03
80
Participants Needed
1
Research Sites
730 weeks
Total Duration
On this page
Sponsors
D
Douglas B. Sawyer
Lead Sponsor
M
MaineHealth
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
CONDITIONS
Official Title
Studies of Neuregulin/ERBB Signaling in Human Heart
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.
You will not qualify if you...
- Less than 18 years of age
- Unwilling or unable to provide informed consent
- Known active myocarditis
- Hypertrophic cardiomyopathy
- Constrictive pericarditis or other significant pericardial disease
- Severe pulmonary hypertension
- Significant renal impairment (Creatinine > 2.5 mg/dL)
- Severe ventricular arrhythmias
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maine Medical Center
Portland, Maine, United States, 04102
Actively Recruiting
Research Team
J
Joanne Burgess, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here